PT43 Cost-Effectiveness Analysis of Prostate-Specific Antigen (PSA)-Based Risk-Adapted Screening in Germany: An Early Economic Evaluation Study
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.1033
https://www.valueinhealthjournal.com/article/S1098-3015(23)04163-3/fulltext
Section Title :
Section Order :
10531
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04163-3&doi=10.1016/j.jval.2023.09.1033